We are armed
to fight!

A clinical-stage biotechnology company in immunotherapy

• Scientific and Technological
  Platforms

  Neoepitopes,
  agonist or antagonist monoclonal antibodies

  +
• Immuno-oncology

  T-cell activation through neoepitopes
  Transforming tumor microenvironment
  suppressive cells into effector cells

  +
• Autoimmune Diseases

  Down regulating T effector cells to decrease immunological reactivity

  Up regulating regulatory
  T-cells to develop immune tolerance

  +
• Partnerships

  Premier international pharma, clinical and academic collaborations to speed up the delivery of our product candidates to patients in need

  +